Physician profile
Ian H Beiser
NPI 1225025737
$1,996.31
in general payments reported to CMS, 2019-2025
29 companies · $146 in 2025
The $146 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $132 · 2021: $40.91 · 2022: $413 · 2023: $547 · 2024: $188 · 2025: $146.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $882.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $881.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $276.11 | 2019-2022 | |
| Treace Medical Concepts, INC. | $198.43 | 2022-2023 | |
| Kerecis Limited | $191.49 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Convatec INC. | $167.67 | 2023-2024 | |
| Nevro Corp. | $149.27 | 2023-2024 | Senza |
| Melinta Therapeutics, LLC | $124.97 | 2019 | |
| Triad Life Sciences INC. | $112.04 | 2022 | |
| Biopro, INC. | $105.49 | 2020 | |
| Amgen INC. | $103.08 | 2025 | Krystexxa |
| Orthofix Medical, INC. | $88.83 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $88.72 | 2021-2023 | Jublia |
| Musculoskeletal Transplant Foundation INC. | $78.11 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $22.84 | 2025 | Exparel |
| Smith+Nephew, INC. | $22.43 | 2024 | Evos, Panta 2, Memofix Super Elastic Nitinol Staple System |
| Boston Scientific Corporation | $22.32 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $20.59 | 2023 | Nuzyra |
| Urgo Medical North America, LLC | $20.32 | 2025 | Urgok2 |
| Medtronic, INC. | $19.46 | 2023 | Intellis Adaptivestim |
| Abbvie INC. | $19.41 | 2024 | |
| Sebela Pharmaceuticals INC. | $19.35 | 2022 | |
| Baudax Bio INC. | $19.34 | 2021 | |
| Osteomed LLC | $18.99 | 2019 | |
| Wright Medical Technology, INC. | $17.97 | 2019 | |
| Merck Sharp & Dohme LLC | $17.00 | 2019 | |
| Horizon Therapeutics Plc | $15.87 | 2019 | |
| Acera Surgical, INC. | $15.63 | 2019 | |
| Medela LLC | $14.98 | 2020 | |
| Stryker Corporation | $14.10 | 2022 | |
| Paragon 28, INC. | $11.50 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ian Beiser listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.